MetLife Investment Management, LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$392,381

+$345,144 QoQ

Shares Held

104,635

+491.4% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 178 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. CTMX ranks #142 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	402,605	$31,511,893
2	PRAX	Praxis Precision Medicines, Inc.	90,543	$30,312,890
3	VRTX	Vertex Pharmaceuticals Inc / Ma	58,072	$28,846,104
4	FTRE	Fortrea Holdings Inc.	1,362,169	$23,701,740
5	AXSM	Axsome Therapeutics, Inc.	89,662	$21,946,567
6	IMNM	Immunome Inc.	859,076	$18,203,820
7	REGN	Regeneron Pharmaceuticals, Inc.	22,880	$14,266,595
8	CYTK	Cytokinetics Inc	140,046	$11,930,518

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$392,381	104,635	+491.4%	Shares	Defined	2026-08-14
2022-03-31	$47,237	17,692	-27.6%	Shares	Defined	2024-05-10
2021-12-31	$105,851	24,446	+147.4%	Shares	Defined	2024-05-17
2021-09-30	$50,289	9,880	-62.2%	Shares	Defined	2024-05-17
2021-06-30	$165,263	26,108	+396.2%	Shares	Defined	2024-05-17
2021-03-31	$40,675	5,262	-65.0%	Shares	Defined	2024-05-17
2020-12-31	$98,420	15,026	0.0%	Shares	Defined	2024-05-24
2020-09-30	$99,922	15,026	-45.0%	Shares	Defined	2024-05-24
2020-06-30	$227,425	27,302	0.0%	Shares	Defined	2024-05-24
2020-03-31	$209,406	27,302	—	Shares	Defined	2023-07-12
No filing history on record for this holder in this stock.